4d Molecular Therapeutics In shares owned by Tower Research Capital
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $19k | 2.1k | 8.69 |
| 2025-06-30 | $28k | 7.7k | 3.71 |
| 2025-03-31 | $15k | 4.8k | 3.23 |
| 2024-12-31 | $280k | 50k | 5.57 |
| 2024-09-30 | $142k | 13k | 10.81 |
| 2024-06-30 | $201k | 9.6k | 20.99 |
| 2024-03-31 | $31k | 982 | 31.86 |
| 2023-09-30 | $14k | 1.1k | 12.71 |
| 2023-06-30 | $55k | 3.0k | 18.07 |
| 2023-03-31 | $143k | 8.4k | 17.05 |
| 2022-12-31 | $0 | 3.7k | 0.00 |
| 2022-09-30 | $35k | 4.4k | 7.92 |
| 2022-06-30 | $48k | 6.9k | 6.95 |
| 2022-03-31 | $27k | 1.8k | 15.15 |
| 2021-12-31 | $81k | 3.7k | 21.84 |
| 2021-09-30 | $84k | 3.1k | 27.05 |
| 2021-06-30 | $22k | 970 | 23.14 |
| 2021-03-31 | $26k | 604 | 43.05 |